CYSTEINE-CONTAINING OR METHIOINE-CONTAINING PEPTIDES WITH IMMUNOMODULATORY EFFECTS

(19)

(11)

EP 0 923 604 A1

(12)

(43)	Date of publication:
	23.06.1999 Bulletin 1999/25

(21)	Application number: 97919833.0

(22)	Date of filing: 04.04.1997

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61K 31/ 70^{( . )}
A61K 35/ 76^{( . )}
A61P 35/ 00^{( . )}
A61P 37/ 02^{( . )}
A61P 37/ 06^{( . )}
C07K 5/ 103^{( . )}
C07K 7/ 04^{( . )}
C07K 7/ 08^{( . )}
A61K 38/ 00^{( . )}

A61K 31/ 00^{( . )}
A61K 35/ 56^{( . )}
A61K 48/ 00^{( . )}
A61P 37/ 00^{( . )}
A61P 37/ 04^{( . )}
C07K 5/ 10^{( . )}
C07K 5/ 117^{( . )}
C07K 7/ 06^{( . )}
C07K 14/ 00^{( . )}

(86)	International application number:
	PCT/SE1997/000574

(87)	International publication number:
	WO 1997/039023 (23.10.1997 Gazette 1997/45)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	LT LV RO SI

(30)

Priority:

12.04.1996 SE 19960001422
23.09.1996 SE 19960003469

(71)	Applicant: Astra Aktiebolag
	151 85 Södertälje (SE)

(72)	Inventors:
	BERGSTRAND, Hakan S-237 35 Bjärred (SE) ERIKSSON, Tomas S-226 51 Lund (SE) LINDVALL, Magnus S-224 65 Lund (SE) SÄRNSTRAND, Bengt S-224 65 Lund (SE)

(54)	CYSTEINE-CONTAINING OR METHIOINE-CONTAINING PEPTIDES WITH IMMUNOMODULATORY EFFECTS